Home > Annual Financials > FERMENTA BIOTECH

FERMENTA BIOTECH Financial Statement Analysis
[BOM: 506414]

The Revenues of FERMENTA BIOTECH have decreased by -4.08% YoY .
The Earnings Per Share (EPS) of FERMENTA BIOTECH has increased by Positive YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

FERMENTA BIOTECH Last 5 Annual Financial Results
[BOM: 506414]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹336 Cr₹350 Cr₹399 Cr₹377 Cr₹293 Cr
Expenses ₹308 Cr₹332 Cr₹336 Cr₹295 Cr₹229 Cr
Operating Profit (Excl OI) ₹28 Cr₹18 Cr₹62 Cr₹83 Cr₹64 Cr
Other Income ₹12 Cr₹8.60 Cr₹8.25 Cr₹8.37 Cr₹14 Cr
Interest ₹17 Cr₹21 Cr₹18 Cr₹19 Cr₹20 Cr
Depreciation ₹25 Cr₹28 Cr₹26 Cr₹20 Cr₹15 Cr
Profit Before Tax ₹-9.87 Cr₹-51 Cr₹27 Cr₹52 Cr₹43 Cr
Profit After Tax ₹-24 Cr₹-53 Cr₹15 Cr₹43 Cr₹60 Cr
Consolidated Net Profit ₹-23 Cr₹-51 Cr₹15 Cr₹46 Cr₹60 Cr
Earnings Per Share (Rs)₹26.35₹-7.99₹-17.70₹5.35₹15.77
PAT Margin (%)16.27-7.15-15.183.7811.27
ROE(%)23.93-8.30-16.114.2713.05
ROCE(%)21.971.58-5.257.5012.62
Total Debt/Equity(x)0.300.480.720.660.66

Key Financials

Market Cap : ₹ 774.5 Cr
Revenue (TTM) : ₹ 527.6 Cr
Net Profit(TTM) : ₹ 103.9 Cr
EPS (TTM) : ₹ 35.4
P/E (TTM) : 7.5

Industry Peers & Returns1W1M1Y
FERMENTA BIOTECH -10.7% -25% -11.1%
SUN PHARMACEUTICAL INDUSTRIES 0.6% 3.6% -12.5%
DIVIS LABORATORIES 1% 9.4% 8%
CIPLA 0.9% 1.2% -0.2%
TORRENT PHARMACEUTICALS 1.7% 1% 1%
DR REDDYS LABORATORIES -0.5% -4.2% -6.3%
MANKIND PHARMA 1.5% -3.5% -10.6%
ZYDUS LIFESCIENCES -0.6% -4.6% -7%
LUPIN -1.6% -4.5% -13.3%


FERMENTA BIOTECH Revenues
[BOM: 506414]

Y-o-Y

-4.08 %

5 Yr CAGR

3.46 %

Years Revenues % Change
Mar2025 ₹336 Cr
-4.08
Mar2024 ₹350 Cr
-12.19
Mar2023 ₹399 Cr
5.63
Mar2022 ₹377 Cr
28.79
Mar2021 ₹293 Cr -


FERMENTA BIOTECH Operating Profit
[BOM: 506414]

Y-o-Y

53.28 %

5 Yr CAGR

-18.85 %

Years Operating Profit % Change
Mar2025 ₹28 Cr
53.28
Mar2024 ₹18 Cr
-70.76
Mar2023 ₹62 Cr
-24.64
Mar2022 ₹83 Cr
28.41
Mar2021 ₹64 Cr -

Operating Margins
Y-o-Y

59.81 %

5 Yr CAGR

-21.56 %

Years Operating Margin% % Change
Mar2025 8.31%
59.81
Mar2024 5.2%
-66.71
Mar2023 15.62%
-28.64
Mar2022 21.89%
-0.27
Mar2021 21.95% -

FERMENTA BIOTECH Profit After Tax
[BOM: 506414]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2025 ₹-23 Cr
Negative
Mar2024 ₹-51 Cr
Negative
Mar2023 ₹15 Cr
-66.06
Mar2022 ₹46 Cr
-23.55
Mar2021 ₹60 Cr -

PAT Margins
Y-o-Y

Positive

5 Yr CAGR

9.61 %

Years PAT Margin(%) % Change
Mar2025 16.27 %
Positive
Mar2024 -7.15 %
Negative
Mar2023 -15.18 %
Negative
Mar2022 3.78 %
-66.46
Mar2021 11.27 % -

FERMENTA BIOTECH Earnings Per Share (EPS)
[BOM: 506414]

Y-o-Y

Positive

5 Yr CAGR

13.69 %

Years EPS % Change
Mar2025 ₹26
Positive
Mar2024 ₹-7.99
Negative
Mar2023 ₹-18
Negative
Mar2022 ₹5.35
-66.07
Mar2021 ₹16 -

FERMENTA BIOTECH Return on Capital Employed (ROCE)
[BOM: 506414]

Y-o-Y

1,290.51 %

5 Yr CAGR

14.87 %

Years ROCE % Change
Mar2025 21.97%
1,290.51
Mar2024 1.58%
Positive
Mar2023 -5.25%
Negative
Mar2022 7.5%
-40.57
Mar2021 12.62% -

FERMENTA BIOTECH Share Price vs Sensex

Current Share Price : ₹263.5
Current MarketCap: ₹ 774.5 Cr
Updated EOD on :Oct 17,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
FERMENTA BIOTECH

-10.7%

-25%

-11.1%

SENSEX

1.8%

1.9%

2.4%

FERMENTA BIOTECH related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE HEALTHCARE 0.5% 0.3% 0.6%
BSE SMALLCAP -0.6% -2.3% -6.3%
No NSE index found

You may also like the below Video Courses


FAQ about FERMENTA BIOTECH Financials


How the annual revenues of FERMENTA BIOTECH have changed ?

The Revenues of FERMENTA BIOTECH have decreased by -4.08% YoY .

How the Earnings per Share (EPS) of FERMENTA BIOTECH have changed?

The Earnings Per Share (EPS) of FERMENTA BIOTECH has increased by Positive YoY .